Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple regimens with levofloxacin vs clarithromycin for Helicobacter pylori eradication
IRCT20220306054205N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amoxicillin, bismuth subsalicylate, levofloxacin, pantoprazole and clarithromycin in Helicobacter pylori infection (2 arms), sponsored by Guilan University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
amoxicillinbismuth subsalicylatelevofloxacinpantoprazoleclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20220306054205N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220306054205N1.